Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

265.40
-11.1300-4.02%
Post-market: 265.400.00000.00%17:18 EDT
Volume:339.74K
Turnover:90.51M
Market Cap:7.16B
PE:9.53
High:276.51
Open:276.51
Low:264.23
Close:276.53
52wk High:343.12
52wk Low:211.43
Shares:26.97M
Float Shares:18.51M
Volume Ratio:0.83
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.85
EPS(LYR):27.85
ROE:10.84%
ROA:1.67%
PB:0.96
PE(LYR):9.53

Loading ...

Upbit will list BIO spot trading

Blockbeats
·
Oct 20, 2025

Bio-Rad Laboratories Inc. to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 17, 2025

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

THOMSON REUTERS
·
Oct 17, 2025

BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in Spain

GlobeNewswire
·
Oct 15, 2025

Binance will add a watch label for WAN, remove watch labels for GPS and MBL, and remove seed labels for some tokens

Blockbeats
·
Oct 09, 2025

Biome Australia (ASX:BIO) Is Making Moderate Use Of Debt

Simply Wall St.
·
Oct 09, 2025

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain

GlobeNewswire
·
Oct 08, 2025

BIO-key International Secures $1.13M Note Agreement

TIPRANKS
·
Oct 04, 2025

KALA BIO Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Sep 30, 2025

Bio-Rad Laboratories Announces New Management Changes Following Passing of Co-Founder Alice Schwartz

Reuters
·
Sep 30, 2025

Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away

THOMSON REUTERS
·
Sep 30, 2025

Ladenburg Thalmann Downgrades KALA BIO to Neutral From Buy

MT Newswires Live
·
Sep 29, 2025

Press Release: Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

Dow Jones
·
Sep 29, 2025

KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint

GlobeNewswire
·
Sep 29, 2025